Raft of changes to listings ticked

Posted 29 April 2024 AM

The PBAC gave recommendations to all except three submissions requesting a change to listing at the March meeting, although a couple of those recommendations did not cover everything the sponsor asked for.

In a move towards healthcare professionals working to the top of their scope, nurses will be able to prescribe Boehringer Ingelheim's Jardiance for eligible adults with symptomatic heart failure regardless of ejection fraction as an adjunct to standard of care therapy, after the PBAC recommended the amendment of the Nurse Practitioner prescribing arrangements relating to Jardiance for the indication, from continuing therapy only to a shared-care model.

To see the whole article, please login